We are live on
!
Find out more
AI
Axiom Investors Portfolio holdings
AUM
$8.99B
1-Year Est. Return
44.68%
This Fund
S&P 500
This Quarter
Est. Return
+2.66%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$3.22B
AUM Growth
+$121M
(+3.9%)
Cap. Flow
+$81.9M
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
38.22%
Holding
150
New
21
Increased
61
Reduced
47
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$53.4M |
| 2 |
Itaú Unibanco
ITUB
|
+$45.2M |
| 3 |
Adobe
ADBE
|
+$42.3M |
| 4 |
Comcast
CMCSA
|
+$42M |
| 5 |
Baidu
BIDU
|
+$38.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$67.5M |
| 2 |
Cognizant
CTSH
|
+$46.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$42.2M |
| 4 |
Sensata Technologies
ST
|
+$33.7M |
| 5 |
CBRE Group
CBRE
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.96% |
| 2 | Communication Services | 17.8% |
| 3 | Technology | 16.92% |
| 4 | Financials | 13.78% |
| 5 | Healthcare | 10.15% |
Similar funds
A
VAS
AI
AI
HI
PEA
WT
SFM
Axiom Investors's Q1 2016 Portfolio in Review
As of Q1 2016, Axiom Investors held 150 positions worth $3.22B, up 3.9% from $3.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Axiom Investors's Q1 2016 filing shows 21 new, 61 increased, 47 reduced and 20 closed positions. Its largest new stake was CVS Health: 549,054 shares worth $57M. The largest sale was Check Point Software Technologies, an estimated $67.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 23% a quarter earlier, followed by Communication Services and Technology.
- Axiom Investors's largest Q1 2016 buy was CVS Health: 549,054 shares worth $57M.
- Axiom Investors added most to Itaú Unibanco in Q1 2016, an estimated $45.2M increase.
- Axiom Investors's biggest Q1 2016 reduction was Check Point Software Technologies, cutting an estimated $67.5M.
- Axiom Investors fully exited Regeneron Pharmaceuticals in Q1 2016, selling an estimated $42.2M.
- Axiom Investors's ten largest holdings make up 38% of its $3.22B portfolio in Q1 2016.
- Axiom Investors opened 21 new positions and closed 20 in Q1 2016.
- Axiom Investors's portfolio value rose 3.9% quarter-over-quarter to $3.22B.
Based on Axiom Investors's 13F filing for Q1 2016, filed 12 May 2016.